Search Query :
6P9A
Hiv-1 protease multiple mutant prs5b with darunavir Deposition Author(s): Agniswamy, J. , Kneller, D.W. , Weber, I.T.
Date: 2019-06-10 Method: X-RAY DIFFRACTION Resolution: 1.66 Å Organism(s): Human Immunodeficiency Virus Type 1 Group M Subtype B (Isolate Bru/Lai) Sequences Data: 6P9A_B , 6P9A_A
6P9B
Hiv-1 protease multiple drug resistant mutant prs5b with amprenavir Deposition Author(s): Agniswamy, J. , Kneller, D.W. , Weber, I.T.
Date: 2019-06-10 Method: X-RAY DIFFRACTION Resolution: 1.75 Å Organism(s): Human Immunodeficiency Virus Type 1 Group M Subtype B (Isolate Bru/Lai) Sequences Data: 6P9B_A , 6P9B_B
6PRF
Hiv-1 protease multiple drug resistant clinical isolate mutant pr20 with grl-14213a Deposition Author(s): Agniswamy, J. , Kneller, D.W. , Weber, I.T.
Date: 2019-07-10 Method: X-RAY DIFFRACTION Resolution: 1.21 Å Organism(s): Human Immunodeficiency Virus Type 1 Group M Subtype Sequences Data: 6PRF_A , 6PRF_B
6U7O
Hiv-1 wild type protease with grl-00819a, with phenyl-boronic-acid as p2'-ligand and with a 6-5-5-ring fused crown-like tetrahydropyranofuran as the p2-ligand Deposition Author(s): Kneller, D.W. , Wang, Y.-F. , Weber, I.T.
Date: 2019-09-03 Method: X-RAY DIFFRACTION Resolution: 1.33 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 6U7O_A , 6U7O_B
6U7P
Hiv-1 wild type protease with grl-03119a, with phenyl-boronic-acid as p2'-ligand and with a hexahydro-4h-furo-pyran as the p2-ligand Deposition Author(s): Kneller, D.W. , Wang, Y.-F. , Weber, I.T.
Date: 2019-09-03 Method: X-RAY DIFFRACTION Resolution: 1.13 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 6U7P_A , 6U7P_B
6VCE
Hiv-1 wild type protease with grl-026-18a, a crown-like tetrahydropyranotetrahydrofuran with a bridged methylene group as a p2 ligand Deposition Author(s): Kneller, D.W. , Wang, Y.-F. , Weber, I.T.
Date: 2019-12-20 Method: X-RAY DIFFRACTION Resolution: 1.18 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 6VCE_A , 6VCE_B
6WQF
Structural plasticity of the sars-cov-2 3cl mpro active site cavity revealed by room temperature x-ray crystallography Deposition Author(s): Coates, L. , Kneller, D.W. , Kovalevsky, A.
Date: 2020-04-28 Method: X-RAY DIFFRACTION Resolution: 2.3 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 6WQF_A
6XB0
Room temperature x-ray crystallography reveals catalytic cysteine in the sars-cov-2 3cl mpro is highly reactive: insights for enzyme mechanism and drug design Deposition Author(s): Coates, L. , Kneller, D.W. , Kovalevsky, A.
Date: 2020-06-05 Method: X-RAY DIFFRACTION Resolution: 1.8 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 6XB0_A
6XB1
Room temperature x-ray crystallography reveals catalytic cysteine in the sars-cov-2 3cl mpro is highly reactive: insights for enzyme mechanism and drug design Deposition Author(s): Coates, L. , Kneller, D.W. , Kovalevsky, A.
Date: 2020-06-05 Method: X-RAY DIFFRACTION Resolution: 1.8 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 6XB1_A
6XB2
Room temperature x-ray crystallography reveals catalytic cysteine in the sars-cov-2 3cl mpro is highly reactive: insights for enzyme mechanism and drug design Deposition Author(s): Coates, L. , Kneller, D.W. , Kovalevsky, A.
Date: 2020-06-05 Method: X-RAY DIFFRACTION Resolution: 2.1 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 6XB2_A